Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 11, 2014, Pages 1596-1607

  Tanaka, Naoki ^a   Takahashi, Shogo ^a   Fang, Zhong Ze ^a,b   Matsubara, Tsutomu ^a,c   Krausz, Kristopher W ^a   Qu, Aijuan ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Osaka Prefecture University   (Japan)

Author keywords

Choline deficiency; Fasting response; Linoleic acid; Lipolysis; Metabolomics; Oleic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; BETA 2 ADRENERGIC RECEPTOR; CARBOXYLESTERASE; CARBOXYLESTERASE 3; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; HORMONE SENSITIVE LIPASE; LINOLEIC ACID; METHIONINE; OLEIC ACID; UNCLASSIFIED DRUG;

ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; FIBROBLAST; LIPOLYSIS; LIVER INJURY; MALE; METABOLOMICS; METHIONINE AND CHOLINE DEFICIENT DIET; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHENOTYPE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION; VITAMIN DEFICIENCY; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

EID: 84907766271     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.08.015     Document Type: Article

References (37)

1. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment. Pharmacol. Ther. 34 2011 274 285
2. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insight Science 332 2011 1519 1523
3. C. Söderberg, P. Stål, J. Askling, H. Glaumann, G. Lindberg, J. Marmur, and R. Hultcrantz Decreased survival of subjects with elevated liver function tests during a 28-year follow-up Hepatology 51 2010 595 602
4. H. Tilg, and A.R. Moschen Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 52 2010 1836 1846
5. B.A. Neuschwander-Tetri Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites Hepatology 52 2010 774 788
6. G.C. Farrell, D. van Rooyen, L. Gan, and S. Chitturi NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications Gut Liver 6 2012 149 171
7. D.M. Torres, C.D. Williams, and S.A. Harrison Features, diagnosis, and treatment of nonalcoholic fatty liver disease Clin. Gastroenterol. Hepatol. 10 2012 837 858
8. C.P. Day, and O.F.W. James Steatohepatitis: a tale of two "hit"? Gastroenterology 114 1998 824 845
9. O. Gyorgy, and H. Goldblatt Observations on the conditions of dietary hepatic injury (necrosis, cirrhosis) in rats J. Exp. Med. 75 1942 355 368
10. N. Tanaka, T. Matsubara, K.W. Krausz, A.D. Patterson, and F.J. Gonzalez Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis Hepatology 56 2012 118 129
11. Z.M. Yao, and D.E. Vance The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes J. Biol. Chem. 263 1988 2998 3004
12. J.R. Idle, and F.J. Gonzalez Metabolomics Cell Metab. 6 2007 348 351
13. T. Matsubara, N. Tanaka, K.W. Krausz, S.K. Manna, D.W. Kang, E.R. Anderson, H. Luecke, A.D. Patterson, Y.M. Shah, and F.J. Gonzalez Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis Cell Metab. 16 2012 634 644
14. R. Zimmermann, A. Lass, G. Haemmerle, and R. Zechner Fate of fat: the role of adipose triglyceride lipase in lipolysis Biochim. Biophys. Acta 1791 2009 494 500
15. L. Zhou, and A. Nilsson Source of eicosanoid precursor fatty acid pools in tissues J. Lipid Res. 42 2001 1521 1542
16. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J. Clin. Invest. 115 2005 1343 1351
17. P. Jha, T. Claudel, A. Baghdasaryan, M. Mueller, E. Halilbasic, S.K. Das, A. Lass, R. Zimmermann, R. Zechner, G. Hoefler, and M. Trauner Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia Hepatology 59 2014 858 869
18. P. Jha, A. Knopf, H. Koefeler, M. Mueller, C. Lackner, G. Hoefler, T. Claudel, and M. Trauner Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH) Biochim. Biophys. Acta 1842 2014 959 970
19. C. von Montfort, N. Matias, A. Fernandez, R. Fucho, L. Conde de la Rosa, M.L. Martinez-Chantar, J.M. Mato, K. Machida, H. Tsukamoto, M.P. Murphy, A. Mansouri, N. Kaplowitz, C. Garcia-Ruiz, and J.C. Fernandez-Checa Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis J. Hepatol. 57 2012 852 859
20. N. Tanaka, K. Moriya, K. Kiyosawa, K. Koike, F.J. Gonzalez, and T. Aoyama PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice J. Clin. Invest. 118 2008 683 694
21. N.E. Sunny, E.J. Parks, J.D. Browning, and S.C. Burgess Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease Cell Metab. 14 2011 804 810
22. I.S. Grimm, W. Schindler, and O. Haluszka Steatohepatitis and fatal hepatic failure after biliopancreatic diversion Am. J. Gastroenterol. 87 1992 775 779
23. N. Tanaka, A. Horiuchi, T. Yokoyama, G. Kaneko, N. Horigome, T. Yamaura, T. Nagaya, M. Komatsu, K. Sano, S. Miyagawa, T. Aoyama, and E. Tanaka Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy J. Gastroenterol. 46 2011 758 768
24. G.P. Ables, C.E. Perrone, D. Orentreich, and N. Orentreich Methionine-restricted C57BL/6 J mice are resistant to diet-induced obesity and insulin resistance but have low bone density PLoS One 7 2012 e51357
25. T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, J.K. Elmquist, R.D. Gerard, S.C. Burgess, R.E. Hammer, D.J. Mangelsdorf, and S.A. Kliewer Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 2007 415 425
26. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, R.A. Owens, J. Gromada, J.T. Brozinick, E.D. Hawkins, V.J. Wroblewski, D.S. Li, F. Mehrbod, S.R. Jaskunas, and A.B. Shanafelt FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
27. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
28. H. Li, Q. Fang, F. Gao, J. Fan, J. Zhou, X. Wang, H. Zhang, X. Pan, Y. Bao, K. Xiang, A. Xu, and W. Jia Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride J. Hepatol. 53 2010 934 940
29. H. Li, K. Dong, Q. Fang, X. Hou, M. Zhou, Y. Bao, K. Xiang, A. Xu, and W. Jia High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China J. Hepatol. 58 2013 557 563
30. K.G. Soni, R. Lehner, P. Metalnikov, P. O'Donnell, M. Semache, W. Gao, K. Ashman, A.V. Pshezhetsky, and G.A. Mitchell Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase J. Biol. Chem. 279 2004 40683 40689
31. H. Okazaki, M. Igarashi, M. Nishi, M. Tajima, M. Sekiya, S. Okazaki, N. Yahagi, K. Ohashi, K. Tsukamoto, M. Amemiya-Kudo, T. Matsuzaka, H. Shimano, N. Yamada, J. Aoki, R. Morikawa, Y. Takanezawa, H. Arai, R. Nagai, T. Kadowaki, J. Osuga, and S. Ishibashi Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol: a potential role in adipocyte lipolysis Diabetes 55 2006 2091 2097
32. E. Wei, Y. Ben Ali, J. Lyon, H. Wang, R. Nelson, V.W. Dolinsky, J.R. Dyck, G. Mitchell, G.S. Korbutt, and R. Lehner Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure Cell Metab. 11 2010 183 193
33. K.T. Ong, M.T. Mashek, S.Y. Bu, A.S. Greenberg, and D.G. Mashek Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning Hepatology 53 2011 116 126
34. T. Nakajima, Y. Kamijo, N. Tanaka, E. Sugiyama, E. Tanaka, K. Kiyosawa, Y. Fukushima, J.M. Peters, F.J. Gonzalez, and T. Aoyama Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage Hepatology 40 2004 972 980
35. F. Caballero, A. Fernández, N. Matías, L. Martínez, R. Fucho, M. Elena, J. Caballeria, A. Morales, J.C. Fernández-Checa, and C. García-Ruiz Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione J. Biol. Chem. 285 2010 18528 18536
36. S.C. Cazanave, J.L. Mott, S.F. Bronk, N.W. Werneburg, C.D. Fingas, X.W. Meng, N. Finnberg, W.S. El-Deiry, S.H. Kaufmann, and G.J. Gores Death receptor 5 signaling promotes hepatocyte lipoapoptosis J. Biol. Chem. 286 2011 39336 39348
37. G. Spiteller Peroxidation of linoleic acid and its relation to aging and age dependent diseases Mech. Ageing Dev. 122 2001 617 657